Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy (semaglutide) for weight management involves more than a weekly injection. It works by acting on GLP-1 receptors in the brain and gut to reduce appetite and slow gastric emptying, and as a prescription-only medicine it requires ongoing clinical supervision throughout treatment. Most people find the first few months involve some adjustment, and a few practical facts make that stretch considerably easier. This page gathers the most clinically relevant things to know, based on the NHS semaglutide guidance and the medicine's prescribing information, so you can go into treatment clear-eyed rather than caught out.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is one of the most common things our prescribers hear: someone arrives expecting to begin on the full maintenance dose, or they feel deflated when the starter pen delivers what feels like a modest 0.25 mg. The reality is that the dose schedule is deliberately gradual, and that pace exists for a good reason. Wegovy's GI side effects — nausea, loose stools, indigestion, sometimes vomiting — are strongly linked to how quickly the dose rises. Starting low lets your digestive system acclimatise before the medicine reaches therapeutic levels.
The NHS page on semaglutide is clear that the full Wegovy schedule runs 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, each step roughly four weeks apart under a prescriber's guidance. That means most people reach maintenance around month five. Rushing the ladder does not improve results; it increases the chance of side effects severe enough to prompt people to stop. Letting the process run at its designed pace is not patience for patience's sake. It is the approach the clinical evidence is built on, including the STEP 1 trial, which reported around 15% average weight reduction over 68 weeks at 2.4 mg.
There is also a newer 7.2 mg dose, approved by the MHRA in January 2026 and available as a dedicated single-dose pen from April 2026 for adults with BMI 30 or above. Whether it is appropriate for any individual is a clinical question. If you are curious about how the dose options compare, you can explore that on the semaglutide overview page.
Nausea is the side effect people talk about most. It is real, and for some people it is significant, but it is also the side effect most likely to ease once your body has adjusted to each dose level. Eating smaller meals, avoiding rich or fatty food around your injection day, and staying hydrated all help. Constipation and diarrhoea can alternate, which catches people off guard. Keeping fibre and fluid intake steady matters throughout treatment, not just in the first week.
More serious signs need prompt attention. Severe stomach pain that spreads to your back, with or without vomiting, can indicate pancreatitis, which the MHRA specifically flagged in a Drug Safety Update in January 2026 for GLP-1 medicines. It is uncommon, but you should seek urgent medical help if that pattern of pain develops. Gallbladder problems, allergic reactions, and significant dehydration from prolonged vomiting or diarrhoea are other situations requiring medical review rather than waiting it out. You can report any suspected side effect directly via the MHRA Yellow Card scheme.
If you want a fuller account of what to expect day to day, the guide on what to do when taking Wegovy covers injection technique, storage and managing the most common symptoms in more detail.
This is the section that surprises people most, and it is genuinely important. Wegovy slows the movement of food through the gut, which means oral medicines taken at the same time may be absorbed differently. For oral contraceptives specifically, NHS guidance advises adding a non-oral contraceptive method (condoms, for example) during the first four weeks of starting Wegovy and for four weeks after every dose increase. If you want a thorough rundown of interactions and practical steps before your first injection, what to know when starting Wegovy brings together the key points worth reviewing in advance. Women on HRT should discuss the same concern with their prescriber, as transdermal forms such as patches or gels are not subject to the same absorption issue.
The same caution applies in reverse for any other oral medicines you take regularly: your prescriber and GP should review your full medicine list before you begin. If you have a planned surgical procedure coming up, you must tell your anaesthetist and surgical team that you are taking Wegovy. The NHS England guidance on weight management injections specifically highlights this, because GLP-1 medicines affect gastric emptying in a way that can carry anaesthetic risk if it is not anticipated. This applies to elective and emergency procedures alike.
Wegovy is not recommended during pregnancy, whilst breastfeeding, or when trying to conceive. It is not licensed for anyone under 18. If any of these circumstances apply or arise during treatment, stopping the medicine and speaking to a clinician promptly is the right step.
Wegovy works best alongside a reduced-calorie diet and increased activity, which is a requirement of the licence, not a rider. Protein intake, hydration and some form of resistance exercise help preserve muscle during weight loss on GLP-1 treatment; these are worth building into your routine early rather than retrofitting them later. For a practical look at how to get the most from the medicine once you are established on it, the page covering what to know about taking Wegovy goes into the habits and adjustments that support long-term progress. Your prescriber should review your progress before any dose increase, and should also look at whether continuing makes sense if you have not achieved at least 5% weight loss after six months on the maintenance dose, that is what NICE recommends in its appraisal of semaglutide for weight management.
If you are weighing up how to access treatment or wondering about private versus NHS routes, there is honest context on both the weight loss treatment overview and the guide to obtaining Wegovy in the UK. For questions about cost and what a private prescription actually covers, the treatment page sets out what is included in one transparent price, without a subscription or auto-renewal. The FAQs also answer a number of the practical questions that come up once treatment is underway.
At nume, every repeat order is reviewed by a real prescriber before it is dispensed. If anything changes in your health or medicines between orders, that review is where it gets caught. Speak to our prescribers if you are thinking about starting, or if you have questions about how the process works.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.